High expression of VEGFC is significantly associated with poor prognosis in various malignancies, including lung cancer [44], gastric cancer [45], thyroid cancer [46], colorectal cancer [47], and HNSCC [48]. This evidence concerns the gene VEGFC and head and neck squamous cell carcinoma.